Three analogues of the model peptide of sequence IRGERA corresponding to the COOH-terminal residues 130-135 of histone H3 were synthesized, and their antigenicity, immunogenicity, and resistance to trypsin were compared to those of the natural L-peptide. The three analogues correspond to the D-enantiomer, containing only D-residues, and two retro-peptides containing NH-CO bonds instead of natural peptide bonds. The chirality of each residue was maintained in the retro-peptide and inverted in the retroinverso-peptide. Antibodies to the four peptide analogues were produced by injecting BALB/c mice with peptides covalently coupled to small unilamellar liposomes containing monophosphoryl lipid A. Each of the four peptide analogues induced IgG antibodies of various subclasses. The IgG3 antibodies reacted similarly with the four analogues, whereas antibodies of the IgGl, IgG2a, and IgG2b isotypes showed strong conformational preferences for certain peptides. The retro-inversopeptide IRGERA mimicked the structure and antigenic activity of the natural L-peptide but not of the D-and retro-peptides, whereas the retro-peptide IRGERA mimicked the D-peptide but not the L-and retro-inverso-peptides. The equilibrium affnity constants (Ka) of three monoclonal antibodies generated against the L-and D-peptides with respect to the four peptide analogues were measured in a biosensor system. Large differences in Ka values were observed when each monoclonal antibody was tested with respect to the four peptides. The use of retro-inverso-peptides to replace natural L-peptides is likely to find many applications in immunodiagnosis and as potential synthetic vaccines.The development of neuropeptides, peptide hormones, peptide antibiotics, or peptide-based synthetic vaccines is strongly impaired by the high susceptibility of peptides to proteolysis, which limits, inter alia, parental and oral administration. For many years intense work has been focused on the synthesis of peptide analogues in the search for mimics with enhanced activity and biological half-lives. Examples of modifications introduced in peptides are the replacement of L-amino acid residues by D-amino acids or by unnatural residues (e.g., sarcosine and 3-alanine) and the modification of peptide bonds (1-3). These changes provide pseudopeptides or peptidomimetics with a higher metabolic stability, since most natural proteases cannot cleave D-amino acid residues and nonpeptide bonds. An important problem encountered with such peptide analogues is the conservation of their biological activity. Recently, the D-form of human immunodeficiency virus type 1 protease has been synthesized (4). As could be expected, the enantiomeric protein displayed reciprocal chiral specificity as the enzyme was unable to cleave the normal L-substrate but did hydrolyze its D-enantiomer. In contrast, Wen and Laursen (5) showed that both the L-and D-form of an a-helical antifreeze polypeptide bound equally well to the same achiral ice substrate, whereas Wade et al. (6) found that the L-and D-e...